Carrier screening panels for Ashkenazi Jews: Is more better?
Open Access
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Genetics in Medicine
- Vol. 7 (3), 185-190
- https://doi.org/10.1097/01.gim.0000156527.87525.8f
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cystic Fibrosis Gene Testing a ChallengePublished by American Medical Association (AMA) ,2003
- A Mutation ofPCDH15among Ashkenazi Jews with the Type 1 Usher SyndromeNew England Journal of Medicine, 2003
- Geographic Distribution of Disease Mutations in the Ashkenazi Jewish Population Supports Genetic Drift over SelectionAmerican Journal of Human Genetics, 2003
- Genetic testing and risk assessment for spinal muscular atrophy (SMA)Human Genetics, 2002
- Carrier Screening for Mucolipidosis Type IV in the American Ashkenazi Jewish PopulationAmerican Journal of Human Genetics, 2002
- Laboratory standards and guidelines for population-based cystic fibrosis carrier screeningGenetics in Medicine, 2001
- Molecular Basis of Mendelian Disorders among JewsMolecular Genetics and Metabolism, 2000
- Screening Jews and Genes: A Consideration of the Ethics of Genetic Screening Within the Jewish Community: Challenges and ResponsesGenetic Testing, 1999
- AfterwordGenetic Testing, 1998
- Tay-Sachs Disease Carrier Screening: A Model for Prevention of Genetic DiseaseGenetic Testing, 1998